Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_4
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (100.0%)

Trials by Status

completed250%
withdrawn125%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Eosinophil-guided Reduction of Inhaled Corticosteroids

NCT04481555
withdrawn

Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)

NCT04402515
unknown

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases

NCT02488590
completedphase_4

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

NCT01985334

Clinical Trials (4)

Showing 4 of 4 trials
NCT04481555Phase 4

Eosinophil-guided Reduction of Inhaled Corticosteroids

Completed
NCT04402515

Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)

Withdrawn
NCT02488590

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases

Unknown
NCT01985334Phase 4

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4